IP
ALXN

Intellectus Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Intellectus Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,942
Closed -$357K – 288
2021
Q2 		$357K Sell
1,942
-342
-15% -$58.7K 0.08% 217
2021
Q1 		$349K Sell
2,284
-251
-10% -$38.8K 0.1% 205
2020
Q4 		$396K Sell
2,535
-823
-25% -$106K 0.12% 177
2020
Q3 		$384K Buy
3,358
+823
+32% +$88.8K 0.15% 160
2020
Q2 		$285K Hold
2,535
– – 0.11% 177
2020
Q1 		$228K Buy
+2,535
New +$249K 0.11% 174
2017
Q3 		– Sell
-36
Closed -$14K – 817
2017
Q2 		$14K Buy
+36
New +$4.19K 0.01% 554

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return